Shire pipeline 'to add $3bn in sales by 2020'
This article was originally published in Scrip
Executive Summary
Shire says drug candidates in its pipeline will contribute $3bn in sales by 2020. The company set out its wares at an R&D day in New York eight weeks after AbbVie pulled out of a $53bn offer for the rare disease specialist following the US Treasury's tightening of tax rules (scripintelligence.com, 16 October 2014).